The Value & Access Collaboration, convened by the National Forum for Heart Disease & Stroke Prevention, responded to the Federal Trade Commission (FTC)’s Request for Information about how large, vertically integrated pharmacy benefits managers’ (PBMs’) business practices affect consumers’ access to healthcare. Twenty-one organizations …
Value & Access Collaboration Provides Consensus Feedback on ICER Draft Evidence Report of Mavacamten
The National Forum’s Value & Access Collaboration provided consensus feedback on the Institute for Clinical and Economic Review (ICER)’s draft evidence report of the assessment for comparative clinical effectiveness and value of mavacamten for hypertrophic cardiomyopathy. Signers included: National Forum for Heart Disease & Stroke …
Magnitude of ASCVD Warrants Higher Priority Than Assigned by Advisory Committee: Important for Patient Access to Therapies
For Immediate Release March 2, 2021 Contact: John M. Clymer Executive Director 202-903-7303 Magnitude of ASCVD Warrants Higher Priority Than Assigned by Advisory Committee Important for Patient Access to Therapies While ICER’s advisory committee judged secondary prevention of atherosclerotic …
National Forum ED Addresses ICER Advisory Committee on High Cholesterol Treatments
Today, on behalf of the National Forum Value & Access Steering Committee and partners, Executive Director John Clymer presented comments to the Institute for Clinical and Economic Review’s (ICER’s) Midwest Comparative Effectiveness Public Advisory Council meeting on its review of high cholesterol treatments. The comments were based on …
Value & Access Steering Committee & Partners Comment on ICER Draft Evidence Report on High Cholesterol Treatment
The National Forum submitted to the Institute for Clinical and Economic Review (ICER) feedback from the Value & Access Steering Committee and partners on ICER’s Draft Evidence Report on Treatments for High Cholesterol. The feedback reflects the consensus of Value & Access Steering Committee members and partners who represent patients, clinical …
What Do Value & Access Really Mean? New Report Documents Changes in Stakeholder Perspectives
FOR IMMEDIATE RELEASE September 8, 2020, 1:00 pm EDT Contact: John M. Clymer Executive Director 202-903-7303 What Do Value & Access Really Mean? New report documents changes in stakeholder perspectives and what the terms mean in 2020 Washington, D.C. – The National Forum for Heart Disease & Stroke …
Call to Expand Access to Tests, Vaccinations Grows Louder
FOR IMMEDIATE RELEASE August 21, 2020, 1:00 pm EDT Contact: John M. Clymer Executive Director 202-903-7303 More Patient Groups Appeal to Congress to Fix Glitch So Americans Have Access to COVID and Flu Testing and Vaccinations Patient groups urging action in next COVID bill represent 200 million …
A Real Way to Strengthen the U.S. Response to COVID-19 That’s Ready to Roll
John M. Clymer Executive Director National Forum for Heart Disease & Stroke Prevention As Congress and the Trump Administration negotiate over the next COVID-19 legislative package, they have an opportunity to strengthen the nation’s response to the pandemic, blunt the health impact of COVID-19 and, at the same time, increase health …
National Forum and Partners Call on Congress and President to Expand Access to Care in COVID-19 Bill
EMBARGOED Until August 6, 2020, 12:30 pm EDT Contact: John M. Clymer Executive Director 202-903-7303 Patients, Consumers, the Underserved, Healthcare Providers and Public Health Call on Congress to Fix a Missing Link So Pharmacies Can Ramp Up COVID Testing and Prepare for Vaccinations Patient groups …